Normal view MARC view ISBD view

Crystallization and preliminary X-ray crystallographic analysis of zebrafish prototype galectin Drgal1-L2. [electronic resource]

By:

Scott, Stacy A

Contributor(s):

Producer: 20110321Description: 1647-51 p. digitalISSN:

1744-3091

Subject(s):

Online resources:

Available from publisher's website

In: Acta crystallographica. Section F, Structural biology and crystallization communications vol. 66

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

101 Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
by Kudelka, A P
102 Intraperitoneal catheters: percutaneous placement with fluoroscopic guidance.
by Kirk, I R
103 Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
by Kudelka, A P
104 Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma.
by Kudelka, A P
105 Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
by Vadhan-Raj, S
106 A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
by Verschraegen, C F
107 Limitations of size as a criterion in the evaluation of adrenal tumors.
by Barnett, C C
108 Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
by Piamsomboon, S
109 A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
by Kudelka, A P
110 Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.
by Kim, D K
111 Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
by Verschraegen, C F
112 Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.
by Kudelka, A P
113 Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinoma.
by Kudelka, A. P.
114 Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
by Freedman, R S
115 Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.
by Kavanagh, J J
116 Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy.
by Lenert, J T
117 An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
by Kudelka, A P
118 A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
by Kudelka, A P
119 Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
by Rahman, Z
120 Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
by Hanania, E G